286 related articles for article (PubMed ID: 15059893)
1. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.
Youssef EM; Chen XQ; Higuchi E; Kondo Y; Garcia-Manero G; Lotan R; Issa JP
Cancer Res; 2004 Apr; 64(7):2411-7. PubMed ID: 15059893
[TBL] [Abstract][Full Text] [Related]
2. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene.
Zhang J; Liu L; Pfeifer GP
Oncogene; 2004 Mar; 23(12):2241-9. PubMed ID: 14691453
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutation analysis of TIG1 (tazarotene-induced gene 1) in human gastric cancer.
Son MS; Kang MJ; Park HC; Chi SG; Kim YH
Oncol Res; 2009; 17(11-12):571-80. PubMed ID: 19806788
[TBL] [Abstract][Full Text] [Related]
7. Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells.
Côté S; Momparler RL
Anticancer Drugs; 1997 Jan; 8(1):56-61. PubMed ID: 9147612
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation associated with polycomb repression in retinoic acid receptor β silencing.
Moison C; Senamaud-Beaufort C; Fourrière L; Champion C; Ceccaldi A; Lacomme S; Daunay A; Tost J; Arimondo PB; Guieysse-Peugeot AL
FASEB J; 2013 Apr; 27(4):1468-78. PubMed ID: 23299856
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor alpha2 is a growth suppressor epigenetically silenced in MCF-7 human breast cancer cells.
Farias EF; Arapshian A; Bleiweiss IJ; Waxman S; Zelent A; Mira-Y-Lopez R
Cell Growth Differ; 2002 Aug; 13(8):335-41. PubMed ID: 12193472
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.
Mizuiri H; Yoshida K; Toge T; Oue N; Aung PP; Noguchi T; Yasui W
Cancer Sci; 2005 Sep; 96(9):571-7. PubMed ID: 16128742
[TBL] [Abstract][Full Text] [Related]
11. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
Côté S; Sinnett D; Momparler RL
Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.
Yuan BZ; Durkin ME; Popescu NC
Cancer Genet Cytogenet; 2003 Jan; 140(2):113-7. PubMed ID: 12645648
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells.
Mongan NP; Gudas LJ
Mol Cancer Ther; 2005 Mar; 4(3):477-86. PubMed ID: 15767557
[TBL] [Abstract][Full Text] [Related]
14. Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells.
Whang YM; Choi EJ; Seo JH; Kim JS; Yoo YD; Kim YH
Cancer Chemother Pharmacol; 2005 Nov; 56(5):543-55. PubMed ID: 15959780
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.
Miasaki FY; Vivaldi A; Ciampi R; Agate L; Collecchi P; Capodanno A; Pinchera A; Elisei R
J Endocrinol Invest; 2008 Aug; 31(8):724-30. PubMed ID: 18852534
[TBL] [Abstract][Full Text] [Related]
17. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
[TBL] [Abstract][Full Text] [Related]
18. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
Fang MZ; Wang Y; Ai N; Hou Z; Sun Y; Lu H; Welsh W; Yang CS
Cancer Res; 2003 Nov; 63(22):7563-70. PubMed ID: 14633667
[TBL] [Abstract][Full Text] [Related]
19. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
[TBL] [Abstract][Full Text] [Related]
20. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
Petty WJ; Li N; Biddle A; Bounds R; Nitkin C; Ma Y; Dragnev KH; Freemantle SJ; Dmitrovsky E
J Natl Cancer Inst; 2005 Nov; 97(22):1645-51. PubMed ID: 16288117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]